ES2118131T3 - Polipeptidos derivados de la proteina endonucleasa del virus de la inmunodeficiencia adquirida humana. - Google Patents

Polipeptidos derivados de la proteina endonucleasa del virus de la inmunodeficiencia adquirida humana.

Info

Publication number
ES2118131T3
ES2118131T3 ES92908719T ES92908719T ES2118131T3 ES 2118131 T3 ES2118131 T3 ES 2118131T3 ES 92908719 T ES92908719 T ES 92908719T ES 92908719 T ES92908719 T ES 92908719T ES 2118131 T3 ES2118131 T3 ES 2118131T3
Authority
ES
Spain
Prior art keywords
viruses
acquired immunodeficiency
polypeptides derived
endonuclease protein
human acquired
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92908719T
Other languages
English (en)
Inventor
Francesca Chiodi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson
Original Assignee
Johnson and Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson filed Critical Johnson and Johnson
Application granted granted Critical
Publication of ES2118131T3 publication Critical patent/ES2118131T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/974Aids related test
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE PRESENTA UNA POLIPEPTIDO DE LA FORMULA: X-GLU-THR-GLY-GIN-GLU-THRALA-PHE-ILE-LEU-LYS-LEU-ALA-GLY-ARG-TRP-PRO-VAL-LYS-Z EN LA X ES UNA CADENA DE ENTRE 1 Y 20 RESIDUOS DE AMINOACIDO O UN GRUPO AMINO-TERMINAL Y Z ES UNA CADENA DE ENTRE 1 Y 20 RESIDUOS DE AMINOACIDO O UN GRUPO CARBOXIDO-TERMINAL. EL POLIPEPTIDO IMITA INMUNOLOGICAMENTE LA ENDONUCLEASA DEL HIV.
ES92908719T 1991-03-15 1992-03-03 Polipeptidos derivados de la proteina endonucleasa del virus de la inmunodeficiencia adquirida humana. Expired - Lifetime ES2118131T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/670,296 US5229364A (en) 1991-03-15 1991-03-15 Polypeptides derived from the human immunodeficiency virus endonuclease protein

Publications (1)

Publication Number Publication Date
ES2118131T3 true ES2118131T3 (es) 1998-09-16

Family

ID=24689836

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92908719T Expired - Lifetime ES2118131T3 (es) 1991-03-15 1992-03-03 Polipeptidos derivados de la proteina endonucleasa del virus de la inmunodeficiencia adquirida humana.

Country Status (13)

Country Link
US (2) US5229364A (es)
EP (1) EP0575522B1 (es)
JP (1) JPH07119235B2 (es)
AT (1) ATE166068T1 (es)
AU (1) AU683812B2 (es)
CA (1) CA2105664C (es)
DE (1) DE69225473T2 (es)
DK (1) DK0575522T3 (es)
ES (1) ES2118131T3 (es)
FI (1) FI111731B (es)
IE (1) IE920832A1 (es)
NO (1) NO308855B1 (es)
WO (1) WO1992016219A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229364A (en) * 1991-03-15 1993-07-20 Francesca Chiodi Polypeptides derived from the human immunodeficiency virus endonuclease protein
WO1993013223A1 (en) * 1991-12-23 1993-07-08 Chiron Corporation Hiv probes for use in solution phase sandwich hybridization assays
US5590213A (en) * 1995-02-15 1996-12-31 David Clark Company Inc. Headset with adjustable headpad
DE19717187A1 (de) * 1997-04-24 1998-10-29 Pagendarm Technologie Gmbh Vorrichtung zur Behandlung, insbesondere Trocknung von Materialbahnen
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
CA2525641A1 (en) 2003-05-12 2004-11-25 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against fiv infection
EP2358462A1 (en) * 2008-11-17 2011-08-24 Dow Global Technologies LLC Methods for reducing airborne formaldehyde

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620330B2 (en) * 1987-05-29 1992-02-20 Smithkline Beckman Corporation Immunodiagnostic assays using chimeric antigens
FR2640877A1 (es) * 1988-12-06 1990-06-29 Centre Nat Rech Scient
AU5184190A (en) * 1989-02-23 1990-09-26 University Of Ottawa Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine
US5229364A (en) * 1991-03-15 1993-07-20 Francesca Chiodi Polypeptides derived from the human immunodeficiency virus endonuclease protein

Also Published As

Publication number Publication date
FI934022A0 (fi) 1993-09-14
JPH07119235B2 (ja) 1995-12-20
CA2105664A1 (en) 1992-09-16
AU1572592A (en) 1992-10-21
WO1992016219A1 (en) 1992-10-01
DE69225473T2 (de) 1998-10-01
JPH06505275A (ja) 1994-06-16
US5229364A (en) 1993-07-20
EP0575522A4 (en) 1994-11-23
US5401628A (en) 1995-03-28
EP0575522A1 (en) 1993-12-29
AU671950B2 (en) 1996-09-19
NO308855B1 (no) 2000-11-06
NO933269L (no) 1993-11-12
DK0575522T3 (da) 1998-10-07
EP0575522B1 (en) 1998-05-13
CA2105664C (en) 1998-08-25
ATE166068T1 (de) 1998-05-15
DE69225473D1 (de) 1998-06-18
FI934022L (fi) 1993-09-14
AU683812B2 (en) 1997-11-20
AU7546896A (en) 1997-02-20
NO933269D0 (no) 1993-09-14
IE920832A1 (en) 1992-09-23
FI111731B (fi) 2003-09-15

Similar Documents

Publication Publication Date Title
DE69432475D1 (de) Von menschlichen t-zellen immunodominante epiropen des virus der c-hepatitis
CL2009002139A1 (es) Peptido sintetico que comprende la secuencia sec id no:6 y sec id no:7 de la proteina gp41 del virus vih con actividad antiretroviral.
DE3851238D1 (de) Antikoagulierende Peptide.
FI881418A7 (fi) Synteettiset peptidiantigeenit HIV-1 -infektion toteamiseksi.
DE3789413D1 (de) Lymphokin-ähnliche Peptide.
RU94046091A (ru) Полипептидные антагонисты бомбезина, фармацевтическая композиция и способ лечения
DE69131662D1 (de) Lipopeptide, T-cytotoxische Lymphocyte aktivierend, und deren Verwendung als Vakzine
ES2118131T3 (es) Polipeptidos derivados de la proteina endonucleasa del virus de la inmunodeficiencia adquirida humana.
DE69011531D1 (de) Von faktor vii abgeleitete peptide mit antihämostatischer wirkung.
DE68924601D1 (de) Reinigung von q-beta-replicase.
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
DE69032258D1 (de) Antikoagulierende Peptide
DK0443848T3 (da) Nyt antiulcermiddel
ATE139259T1 (de) Selbstantigen der primären lebercirrhose
DK0732339T3 (da) Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf
DE69002881D1 (de) Peptide und deren Benutzung.
ES2071038T3 (es) Peptidos asociados al hiv.
ATE98962T1 (de) Menschliche rhinoviruspeptide.
DE69328488D1 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus
MX9206294A (es) Inhibidores de proteasa de vih
DE69006311D1 (de) Antimetastatische peptide.
DE69002234D1 (de) Ultraschallbehandlung von teigerzeugnissen.
ATE83382T1 (de) Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff.
RU93045696A (ru) Ингибиторы протеазы вируса иммунодефицита человека, полезные для лечения спида
DE3879183D1 (de) Entladungselektrodenmaterial.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 575522

Country of ref document: ES